Pharmapark Will Market Prestige's Trastuzumab In Russia

 
• By Dave Wallace

Prestige BioPharma has struck a deal with Pharmapark to market Prestige’s trastuzumab biosimilar in the Russian Federation.

Russia
The Russian Deal Comes Hot On the Heels Of A European Tie-Up With Mundipharma • Source: Shutterstock

More from Deals

More from Business